Skip to content
#gene editing Review Open access

Advances in Exosome Engineering for Cardiovascular Applications

Oct 2026 · Advances in Modern Biomedicine · Vol 2, pp. 1-13 · 0 citations · 71 references
Extracellular vesicles in disease

TL;DR

This narrative review summarizes exosome engineering strategies and their therapeutic use in cell-free therapy and examines preclinical and clinical data comparing engineered exosomes with naïve exosomes to demonstrate their superiority.

Abstract

Exosomes have emerged as favorable natural carriers of theragnostic molecules. Once considered the “disposal bags of the cells” for cellular metabolic waste, they have emerged as central players in intercellular communication. They carry bioactive-molecule cargo from donor cells to recipient cells, which respond to these signals. The cargo delivered in this process is diverse, encompassing proteins, nucleic acids, small molecules, and even gene-editing tools. Recipient cells take up cargo via one or more mechanisms, including receptor-mediated endocytosis, membrane fusion, or phagocytosis. To enhance their therapeutic efficacy, researchers have developed protocols to engineer exosomes by modifying their cargo profile and surface characteristics for site-specific delivery of bioactive molecules. Compared with their native counterparts, engineered exosomes are expected to be more therapeutically efficacious at lower doses while minimizing the undesired effects often caused by non-specific tissue uptake. While the exosomal cargo profile depends on pre- and post-loading strategies (e.g., electroporation, sonication, membrane permeabilization, or chemical transfection), multiple approaches can modify surface membrane characteristics, including genetic modulation, chemical modification, and physical and hybrid approaches. Each cargo-profile modulation and surface-modification approach has respective advantages and limitations. This narrative review summarizes exosome engineering strategies and their therapeutic use in cell-free therapy. It also examines preclinical and clinical data comparing engineered exosomes with naïve exosomes to demonstrate their superiority.

Read PDF

Similar papers

Oct 2026

Exosome-Based Targeted Drug Delivery Systems: Current Advances and Challenges

Exosomes are naturally occurring nanovesicles (30–150nm) that serve as biological carriers for the targeted delivery of medicinal substances. Their membrane composition facilitates passage over physiological barriers, such as the blood-brain barrier, and offers good compatibility with bodily tissues. Using methods like...

Dhananjay A. Deore, S. Jadhav, S. Mahajan · 0 citations
Review Open access Oct 2026

A review of exosomes as nanomedicine for antimicrobial delivery and combating antimicrobial resistance.

This review consolidates current advances in exosome biology, including their biogenesis, isolation, characterization, and engineering for antimicrobial applications, and identifies EV-based systems may help address selected antimicrobial resistance (AMR) challenges by enabling delivery of antibiotics, antimicrobial pe...

Y. Choonara, K. Mnqiwu, M. Chougule et al. · 0 citations
Review Open access Nov 2026

Exosomes in regenerative medicine from biological messengers to engineered nanocarriers for precision therapeutics

Exosomes have emerged as a promising class of next-generation nanocarriers at the intersection of regenerative medicine and drug delivery. Compared with conventional synthetic nanocarriers and stem cell-based therapies, exosomes offer unique advantages, including intrinsic biocompatibility, low immunogenicity, blood-ba...

Shampa M. Ghosh, Rakesh Bhaskar, Krishna Kumar Singh et al. · 0 citations
Review Open access Sep 2026

Extracellular vesicles as biomarkers and therapeutic nanocarriers in cancer.

ABSTRACT Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are lipid bilayer-bound nanoparticles secreted by various cell types. EVs mediate intercellular communication by selectively transporting bioactive molecules including proteins, lipids, and nucleic acids. This review compreh...

Shuang Ma, Ying-Cong Zhou, Zi-Yi Li et al. · 0 citations
#gene editing Review Open access Oct 2026

Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy

Exosomes are an evolved sub-type of extracellular vesicles (EVs) that have gained popularity in recent years as a novel biological nanocarrier system for targeted precision therapy in cancer owing to their excellent biocompatibility, low immunogenicity, and high stability. While other artificial systems can only delive...

Mohd Masih Uzzaman Khan, M. A. Khan, Mohd Azam et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.